Terkko Navigator / Lancet Infectious Diseases

Anticipating outcomes for patients with COVID-19 and identifying prognosis patterns

Scaling up COVID-19 rapid antigen tests: promises and challenges

Correction to Lancet Infect Dis 2021; published online Jan 21. https://doi.org/10.1016/S1473-3099(20)30942-7

Correction to Lancet Infect Dis 2020; published online Feb 16. https://doi.org/10.1016/S1473-3099(20)30784-2

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity

What does 95% COVID-19 vaccine efficacy really mean?

BCG: new life for a centenarian vaccine

BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Micro

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products

Correction to Lancet Infect Dis 2021; online Feb 3. https://doi.org/10.1016/S1473-3099(21)00043-8

Correction to Lancet Infect Dis 2021; published online Jan 20. https://doi.org/10.1016/S1473-3099(20)30990-7

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran

Cardiac safety of multidrug-resistant tuberculosis treatment: moving towards individualised monitoring

Genomic-informed pathogen surveillance in Africa: opportunities and challenges

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

The COVID-19 exit strategy—why we need to aim low

Correction to Lancet Infect Dis 2020; 20: 1263–72

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

Cross-protective potential of a MF59-adjuvanted quadrivalent influenza vaccine in older adults

Correction to Lancet Infect Dis 2020; published online Dec 8. https://doi.org/10.1016/S1473-3099(20)30927-0

CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants

Correction to Lancet Infect Dis 2021; published online Jan 29. https://doi.org/10.1016/S1473-3099(20)30692-7

Long COVID: tackling a multifaceted condition requires a multidisciplinary approach

In favour of a bespoke COVID-19 vaccines compensation scheme

Inactivated COVID-19 vaccines to make a global impact

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Understanding the drivers of transmission of SARS-CoV-2

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study

Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis

Has the bubble burst for transcriptomics in tuberculosis diagnosis?

Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode

Transcriptomic signatures have a place in short-term prediction of incident tuberculosis

Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Correction to Lancet Infect Dis 2020; 20: 1263–72

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Immunity against diphtheria among children aged 5–17 years in India, 2017–18: a cross-sectional, population-based serosurvey

Optimism and caution for an inactivated COVID-19 vaccine

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection

Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study

Strange Bedfellows: Adventures in the Science, History, and Surprising Secrets of STDs, Ina Park. Flatiron Books (2020), 320, Written by US$27·99, ISBN: 978-1250206626

COVID-19 through the Latinx infectious disease doctor's eyes

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results

Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study

Long COVID in the skin: a registry analysis of COVID-19 dermatological duration

An exceptional vaccination policy in exceptional circumstances